Medium chain triglycerides and hepatic encephalopathy
Open Access
- 1 March 1974
- Vol. 15 (3) , 180-184
- https://doi.org/10.1136/gut.15.3.180
Abstract
The oral administration of short (C6) and medium (C8 and (C10) chain triglycerides produced no clinical or electroencephalographic changes in patients with cirrhosis of the liver. Arterial ammonia levels were also monitored in these patients and showed no significant change after medium chain triglycerides. It was concluded that medium chain triglycerides, known to be of potential value in the treatment of malabsorption in patients with cirrhosis, are not clinically contraindicated, even in patients with evidence of hepatic encephalopathy.Keywords
This publication has 18 references indexed in Scilit:
- A new method for evaluation of portasystemic shunting. The rectal octanoate tolerance test.1969
- Effects of Chlorpromazine in Patients with Hepatic DiseaseBMJ, 1969
- ENCEPHALOPATHY AFTER PORTACAVAL ANASTOMOSISThe Lancet, 1968
- Medium-chain triglyceride diet: its use in treatment of liver disease.BMJ, 1966
- Pathogenesis of hepatic coma.1966
- Pathogenesis of Hepatic ComaArchives of internal medicine (1960), 1966
- Medium and long chain fat absorption in patients with cirrhosis.Journal of Clinical Investigation, 1966
- DIFFERENCES IN ABSORPTION OF THE VARIOUS FATTY ACIDS STUDIED IN CHILDREN WITH STEATORRHEAJournal of Clinical Investigation, 1962
- A STUDY ON THE NARCOTIC ACTION OF THE SHORT CHAIN FATTY ACIDS 1Journal of Clinical Investigation, 1956
- THE PLASMA “AMMONIA” AND GLUTAMINE CONTENT IN PATIENTS WITH HEPATIC COMA 1Journal of Clinical Investigation, 1954